世界の高血圧薬市場 2019年

【英語タイトル】Global High Blood Pressure Drugs (Hypertension) Market Professional Survey Report 2019

QYResearchが出版した調査資料(DATA909X09003)・商品コード:DATA909X09003
・発行会社(調査会社):QYResearch
・発行日:2019年11月20日
・ページ数:112
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥367,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥551,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥735,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、高血圧薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ACEI、CCB、ARBに、用途別には、病院薬局、小売薬局、オンライン薬局にセグメント区分し、高血圧薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・高血圧薬の世界市場概要
・高血圧薬の製造コスト構成分析
・高血圧薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・高血圧薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・高血圧薬のセグメント分析(種類別)
(ACEI、CCB、ARB)
・高血圧薬のセグメント分析(用途別)
(病院薬局、小売薬局、オンライン薬局)
・高血圧薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Eli Lilly、Pfizer、Bayer、Symplmed、Novartis、Merck、Sanofi、Boryung、Reata Pharmaceuticals、Lung Biotechnology、Yuhan、Takeda、Alvogen、)
・高血圧薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

The global High Blood Pressure Drugs (Hypertension) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on High Blood Pressure Drugs (Hypertension) volume and value at global level, regional level and company level. From a global perspective, this report represents overall High Blood Pressure Drugs (Hypertension) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of High Blood Pressure Drugs (Hypertension) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their High Blood Pressure Drugs (Hypertension) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Eli Lilly
Pfizer
Bayer
Symplmed
Novartis
Merck
Sanofi
Boryung
Reata Pharmaceuticals
Lung Biotechnology
Yuhan
Takeda
Alvogen

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
ACEI
CCB
ARB

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of High Blood Pressure Drugs (Hypertension)
1.1 Definition of High Blood Pressure Drugs (Hypertension)
1.2 High Blood Pressure Drugs (Hypertension) Segment by Type
1.2.1 Global High Blood Pressure Drugs (Hypertension) Production Growth Rate Comparison by Types (2014-2025)
1.2.2 ACEI
1.2.3 CCB
1.2.4 ARB
1.3 High Blood Pressure Drugs (Hypertension) Segment by Applications
1.3.1 Global High Blood Pressure Drugs (Hypertension) Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global High Blood Pressure Drugs (Hypertension) Overall Market
1.4.1 Global High Blood Pressure Drugs (Hypertension) Revenue (2014-2025)
1.4.2 Global High Blood Pressure Drugs (Hypertension) Production (2014-2025)
1.4.3 North America High Blood Pressure Drugs (Hypertension) Status and Prospect (2014-2025)
1.4.4 Europe High Blood Pressure Drugs (Hypertension) Status and Prospect (2014-2025)
1.4.5 China High Blood Pressure Drugs (Hypertension) Status and Prospect (2014-2025)
1.4.6 Japan High Blood Pressure Drugs (Hypertension) Status and Prospect (2014-2025)
1.4.7 Southeast Asia High Blood Pressure Drugs (Hypertension) Status and Prospect (2014-2025)
1.4.8 India High Blood Pressure Drugs (Hypertension) Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of High Blood Pressure Drugs (Hypertension)
2.3 Manufacturing Process Analysis of High Blood Pressure Drugs (Hypertension)
2.4 Industry Chain Structure of High Blood Pressure Drugs (Hypertension)

3 Development and Manufacturing Plants Analysis of High Blood Pressure Drugs (Hypertension)
3.1 Capacity and Commercial Production Date
3.2 Global High Blood Pressure Drugs (Hypertension) Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of High Blood Pressure Drugs (Hypertension)
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 High Blood Pressure Drugs (Hypertension) Production and Capacity Analysis
4.2 High Blood Pressure Drugs (Hypertension) Revenue Analysis
4.3 High Blood Pressure Drugs (Hypertension) Price Analysis
4.4 Market Concentration Degree

5 High Blood Pressure Drugs (Hypertension) Regional Market Analysis
5.1 High Blood Pressure Drugs (Hypertension) Production by Regions
5.1.1 Global High Blood Pressure Drugs (Hypertension) Production by Regions
5.1.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Regions
5.2 High Blood Pressure Drugs (Hypertension) Consumption by Regions
5.3 North America High Blood Pressure Drugs (Hypertension) Market Analysis
5.3.1 North America High Blood Pressure Drugs (Hypertension) Production
5.3.2 North America High Blood Pressure Drugs (Hypertension) Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America High Blood Pressure Drugs (Hypertension) Import and Export
5.4 Europe High Blood Pressure Drugs (Hypertension) Market Analysis
5.4.1 Europe High Blood Pressure Drugs (Hypertension) Production
5.4.2 Europe High Blood Pressure Drugs (Hypertension) Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe High Blood Pressure Drugs (Hypertension) Import and Export
5.5 China High Blood Pressure Drugs (Hypertension) Market Analysis
5.5.1 China High Blood Pressure Drugs (Hypertension) Production
5.5.2 China High Blood Pressure Drugs (Hypertension) Revenue
5.5.3 Key Manufacturers in China
5.5.4 China High Blood Pressure Drugs (Hypertension) Import and Export
5.6 Japan High Blood Pressure Drugs (Hypertension) Market Analysis
5.6.1 Japan High Blood Pressure Drugs (Hypertension) Production
5.6.2 Japan High Blood Pressure Drugs (Hypertension) Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan High Blood Pressure Drugs (Hypertension) Import and Export
5.7 Southeast Asia High Blood Pressure Drugs (Hypertension) Market Analysis
5.7.1 Southeast Asia High Blood Pressure Drugs (Hypertension) Production
5.7.2 Southeast Asia High Blood Pressure Drugs (Hypertension) Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia High Blood Pressure Drugs (Hypertension) Import and Export
5.8 India High Blood Pressure Drugs (Hypertension) Market Analysis
5.8.1 India High Blood Pressure Drugs (Hypertension) Production
5.8.2 India High Blood Pressure Drugs (Hypertension) Revenue
5.8.3 Key Manufacturers in India
5.8.4 India High Blood Pressure Drugs (Hypertension) Import and Export

6 High Blood Pressure Drugs (Hypertension) Segment Market Analysis (by Type)
6.1 Global High Blood Pressure Drugs (Hypertension) Production by Type
6.2 Global High Blood Pressure Drugs (Hypertension) Revenue by Type
6.3 High Blood Pressure Drugs (Hypertension) Price by Type

7 High Blood Pressure Drugs (Hypertension) Segment Market Analysis (by Application)
7.1 Global High Blood Pressure Drugs (Hypertension) Consumption by Application
7.2 Global High Blood Pressure Drugs (Hypertension) Consumption Market Share by Application (2014-2019)

8 High Blood Pressure Drugs (Hypertension) Major Manufacturers Analysis
8.1 Eli Lilly
8.1.1 Eli Lilly High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
8.1.2 Eli Lilly Product Introduction, Application and Specification
8.1.3 Eli Lilly High Blood Pressure Drugs (Hypertension) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer High Blood Pressure Drugs (Hypertension) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bayer
8.3.1 Bayer High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
8.3.2 Bayer Product Introduction, Application and Specification
8.3.3 Bayer High Blood Pressure Drugs (Hypertension) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Symplmed
8.4.1 Symplmed High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
8.4.2 Symplmed Product Introduction, Application and Specification
8.4.3 Symplmed High Blood Pressure Drugs (Hypertension) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Novartis
8.5.1 Novartis High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
8.5.2 Novartis Product Introduction, Application and Specification
8.5.3 Novartis High Blood Pressure Drugs (Hypertension) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Merck
8.6.1 Merck High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
8.6.2 Merck Product Introduction, Application and Specification
8.6.3 Merck High Blood Pressure Drugs (Hypertension) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sanofi
8.7.1 Sanofi High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
8.7.2 Sanofi Product Introduction, Application and Specification
8.7.3 Sanofi High Blood Pressure Drugs (Hypertension) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Boryung
8.8.1 Boryung High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
8.8.2 Boryung Product Introduction, Application and Specification
8.8.3 Boryung High Blood Pressure Drugs (Hypertension) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Reata Pharmaceuticals
8.9.1 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
8.9.2 Reata Pharmaceuticals Product Introduction, Application and Specification
8.9.3 Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Lung Biotechnology
8.10.1 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
8.10.2 Lung Biotechnology Product Introduction, Application and Specification
8.10.3 Lung Biotechnology High Blood Pressure Drugs (Hypertension) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Yuhan
8.12 Takeda
8.13 Alvogen

9 Development Trend of Analysis of High Blood Pressure Drugs (Hypertension) Market
9.1 Global High Blood Pressure Drugs (Hypertension) Market Trend Analysis
9.1.1 Global High Blood Pressure Drugs (Hypertension) Market Size (Volume and Value) Forecast 2019-2025
9.2 High Blood Pressure Drugs (Hypertension) Regional Market Trend
9.2.1 North America High Blood Pressure Drugs (Hypertension) Forecast 2019-2025
9.2.2 Europe High Blood Pressure Drugs (Hypertension) Forecast 2019-2025
9.2.3 China High Blood Pressure Drugs (Hypertension) Forecast 2019-2025
9.2.4 Japan High Blood Pressure Drugs (Hypertension) Forecast 2019-2025
9.2.5 Southeast Asia High Blood Pressure Drugs (Hypertension) Forecast 2019-2025
9.2.6 India High Blood Pressure Drugs (Hypertension) Forecast 2019-2025
9.3 High Blood Pressure Drugs (Hypertension) Market Trend (Product Type)
9.4 High Blood Pressure Drugs (Hypertension) Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 High Blood Pressure Drugs (Hypertension) Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of High Blood Pressure Drugs (Hypertension)
Table Global High Blood Pressure Drugs (Hypertension) Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global High Blood Pressure Drugs (Hypertension) Production Market Share by Types in 2018
Figure ACEI Product Picture
Figure CCB Product Picture
Figure ARB Product Picture
Table Global High Blood Pressure Drugs (Hypertension) Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global High Blood Pressure Drugs (Hypertension) Consumption Market Share by Applications in 2018
Figure Hospital Pharmacy
Figure Retail Pharmacy
Figure Online Pharmacy
Figure Global High Blood Pressure Drugs (Hypertension) Revenue (Million USD) (2014-2025)
Figure Global High Blood Pressure Drugs (Hypertension) Production (K Units) (2014-2025)
Figure North America High Blood Pressure Drugs (Hypertension) Market Size (Million USD) (2014-2025)
Figure Europe High Blood Pressure Drugs (Hypertension) Market Size (Million USD) (2014-2025)
Figure China High Blood Pressure Drugs (Hypertension) Market Size (Million USD) (2014-2025)
Figure Japan High Blood Pressure Drugs (Hypertension) Market Size (Million USD) (2014-2025)
Figure Southeast Asia High Blood Pressure Drugs (Hypertension) Market Size (Million USD) (2014-2025)
Figure India High Blood Pressure Drugs (Hypertension) Market Size (Million USD) (2014-2025)
Table High Blood Pressure Drugs (Hypertension) Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of High Blood Pressure Drugs (Hypertension) in 2018
Figure Manufacturing Process Analysis of High Blood Pressure Drugs (Hypertension)
Figure Industry Chain Structure of High Blood Pressure Drugs (Hypertension)
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global High Blood Pressure Drugs (Hypertension) Manufacturing Plants Distribution
Table High Blood Pressure Drugs (Hypertension) Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table High Blood Pressure Drugs (Hypertension) Capacity (K Units) of Major Manufacturers (2014-2019)
Table High Blood Pressure Drugs (Hypertension) Production (K Units) of Major Manufacturers (2014-2019)
Table High Blood Pressure Drugs (Hypertension) Production Market Share of Major Manufacturers (2014-2019)
Figure High Blood Pressure Drugs (Hypertension) Production Share by Manufacturers in 2018
Table High Blood Pressure Drugs (Hypertension) Revenue (Million US$) of Major Manufacturers (2014-2019)
Table High Blood Pressure Drugs (Hypertension) Revenue Market Share of Major Manufacturers (2014-2019)
Figure High Blood Pressure Drugs (Hypertension) Revenue Share by Manufacturers in 2018
Table High Blood Pressure Drugs (Hypertension) Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global High Blood Pressure Drugs (Hypertension) Production by Regions 2014-2019 (K Units)
Table Global High Blood Pressure Drugs (Hypertension) Production Market Share by Regions 2014-2019
Figure Global High Blood Pressure Drugs (Hypertension) Production Market Share by Regions in 2018
Table Global High Blood Pressure Drugs (Hypertension) Revenue by Regions 2014-2019 (Million USD)
Table Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Regions 2014-2019
Figure Global High Blood Pressure Drugs (Hypertension) Revenue Market Share by Regions in 2018
Table Global High Blood Pressure Drugs (Hypertension) Consumption by Regions 2014-2019 (K Units)
Table Global High Blood Pressure Drugs (Hypertension) Consumption Market Share by Regions 2014-2019
Figure North America High Blood Pressure Drugs (Hypertension) Production Growth Rate 2014-2019 (K Units)
Figure North America High Blood Pressure Drugs (Hypertension) Revenue Growth Rate 2014-2019 (Million USD)
Table North America High Blood Pressure Drugs (Hypertension) Production, Consumption Import and Export (K Units)
Figure Europe High Blood Pressure Drugs (Hypertension) Production Growth Rate 2014-2019 (K Units)
Figure Europe High Blood Pressure Drugs (Hypertension) Revenue Growth Rate 2014-2019 (Million USD)
Table Europe High Blood Pressure Drugs (Hypertension) Production, Consumption Import and Export (K Units)
Figure China High Blood Pressure Drugs (Hypertension) Production Growth Rate 2014-2019 (K Units)
Figure China High Blood Pressure Drugs (Hypertension) Revenue Growth Rate 2014-2019 (Million USD)
Table China High Blood Pressure Drugs (Hypertension) Production, Consumption Import and Export (K Units)
Figure Japan High Blood Pressure Drugs (Hypertension) Production Growth Rate 2014-2019 (K Units)
Figure Japan High Blood Pressure Drugs (Hypertension) Revenue Growth Rate 2014-2019 (Million USD)
Table Japan High Blood Pressure Drugs (Hypertension) Production, Consumption Import and Export (K Units)
Figure Southeast Asia High Blood Pressure Drugs (Hypertension) Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia High Blood Pressure Drugs (Hypertension) Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia High Blood Pressure Drugs (Hypertension) Production, Consumption Import and Export (K Units)
Figure India High Blood Pressure Drugs (Hypertension) Production Growth Rate 2014-2019 (K Units)
Figure India High Blood Pressure Drugs (Hypertension) Revenue Growth Rate 2014-2019 (Million USD)
Table India High Blood Pressure Drugs (Hypertension) Production, Consumption Import and Export (K Units)
Figure Global Consumption High Blood Pressure Drugs (Hypertension) Market Share by Application (2014-2019)
Figure Global Value (Consumption) High Blood Pressure Drugs (Hypertension) Market Share by Application (2014-2019)
Table Eli Lilly High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Eli Lilly High Blood Pressure Drugs (Hypertension) Product Introduction, Application and Specification
Table Eli Lilly High Blood Pressure Drugs (Hypertension) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly High Blood Pressure Drugs (Hypertension) Production Growth Rate (2014-2019)
Table Eli Lilly High Blood Pressure Drugs (Hypertension) Production Market Share (2014-2019)
Figure Eli Lilly High Blood Pressure Drugs (Hypertension) Revenue Market Share (2014-2019)
Table Eli Lilly High Blood Pressure Drugs (Hypertension) Main Business and Markets Served
Table Pfizer High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Pfizer High Blood Pressure Drugs (Hypertension) Product Introduction, Application and Specification
Table Pfizer High Blood Pressure Drugs (Hypertension) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer High Blood Pressure Drugs (Hypertension) Production Growth Rate (2014-2019)
Table Pfizer High Blood Pressure Drugs (Hypertension) Production Market Share (2014-2019)
Figure Pfizer High Blood Pressure Drugs (Hypertension) Revenue Market Share (2014-2019)
Table Pfizer High Blood Pressure Drugs (Hypertension) Main Business and Markets Served
Table Bayer High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Bayer High Blood Pressure Drugs (Hypertension) Product Introduction, Application and Specification
Table Bayer High Blood Pressure Drugs (Hypertension) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer High Blood Pressure Drugs (Hypertension) Production Growth Rate (2014-2019)
Table Bayer High Blood Pressure Drugs (Hypertension) Production Market Share (2014-2019)
Figure Bayer High Blood Pressure Drugs (Hypertension) Revenue Market Share (2014-2019)
Table Bayer High Blood Pressure Drugs (Hypertension) Main Business and Markets Served
Table Symplmed High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Symplmed High Blood Pressure Drugs (Hypertension) Product Introduction, Application and Specification
Table Symplmed High Blood Pressure Drugs (Hypertension) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Symplmed High Blood Pressure Drugs (Hypertension) Production Growth Rate (2014-2019)
Table Symplmed High Blood Pressure Drugs (Hypertension) Production Market Share (2014-2019)
Figure Symplmed High Blood Pressure Drugs (Hypertension) Revenue Market Share (2014-2019)
Table Symplmed High Blood Pressure Drugs (Hypertension) Main Business and Markets Served
Table Novartis High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Novartis High Blood Pressure Drugs (Hypertension) Product Introduction, Application and Specification
Table Novartis High Blood Pressure Drugs (Hypertension) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis High Blood Pressure Drugs (Hypertension) Production Growth Rate (2014-2019)
Table Novartis High Blood Pressure Drugs (Hypertension) Production Market Share (2014-2019)
Figure Novartis High Blood Pressure Drugs (Hypertension) Revenue Market Share (2014-2019)
Table Novartis High Blood Pressure Drugs (Hypertension) Main Business and Markets Served
Table Merck High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Merck High Blood Pressure Drugs (Hypertension) Product Introduction, Application and Specification
Table Merck High Blood Pressure Drugs (Hypertension) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck High Blood Pressure Drugs (Hypertension) Production Growth Rate (2014-2019)
Table Merck High Blood Pressure Drugs (Hypertension) Production Market Share (2014-2019)
Figure Merck High Blood Pressure Drugs (Hypertension) Revenue Market Share (2014-2019)
Table Merck High Blood Pressure Drugs (Hypertension) Main Business and Markets Served
Table Sanofi High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Sanofi High Blood Pressure Drugs (Hypertension) Product Introduction, Application and Specification
Table Sanofi High Blood Pressure Drugs (Hypertension) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi High Blood Pressure Drugs (Hypertension) Production Growth Rate (2014-2019)
Table Sanofi High Blood Pressure Drugs (Hypertension) Production Market Share (2014-2019)
Figure Sanofi High Blood Pressure Drugs (Hypertension) Revenue Market Share (2014-2019)
Table Sanofi High Blood Pressure Drugs (Hypertension) Main Business and Markets Served
Table Boryung High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Boryung High Blood Pressure Drugs (Hypertension) Product Introduction, Application and Specification
Table Boryung High Blood Pressure Drugs (Hypertension) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boryung High Blood Pressure Drugs (Hypertension) Production Growth Rate (2014-2019)
Table Boryung High Blood Pressure Drugs (Hypertension) Production Market Share (2014-2019)
Figure Boryung High Blood Pressure Drugs (Hypertension) Revenue Market Share (2014-2019)
Table Boryung High Blood Pressure Drugs (Hypertension) Main Business and Markets Served
Table Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Product Introduction, Application and Specification
Table Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Production Growth Rate (2014-2019)
Table Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Production Market Share (2014-2019)
Figure Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Revenue Market Share (2014-2019)
Table Reata Pharmaceuticals High Blood Pressure Drugs (Hypertension) Main Business and Markets Served
Table Lung Biotechnology High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Lung Biotechnology High Blood Pressure Drugs (Hypertension) Product Introduction, Application and Specification
Table Lung Biotechnology High Blood Pressure Drugs (Hypertension) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Lung Biotechnology High Blood Pressure Drugs (Hypertension) Production Growth Rate (2014-2019)
Table Lung Biotechnology High Blood Pressure Drugs (Hypertension) Production Market Share (2014-2019)
Figure Lung Biotechnology High Blood Pressure Drugs (Hypertension) Revenue Market Share (2014-2019)
Table Lung Biotechnology High Blood Pressure Drugs (Hypertension) Main Business and Markets Served
Table Yuhan High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Takeda High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Table Alvogen High Blood Pressure Drugs (Hypertension) Production Sites and Area Served
Figure Global High Blood Pressure Drugs (Hypertension) Production (K Units) Growth Rate Forecast 2019-2025
Figure Global High Blood Pressure Drugs (Hypertension) Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global High Blood Pressure Drugs (Hypertension) Sales Price (USD/Unit) Forecast 2019-2025
Figure North America High Blood Pressure Drugs (Hypertension) Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America High Blood Pressure Drugs (Hypertension) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe High Blood Pressure Drugs (Hypertension) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe High Blood Pressure Drugs (Hypertension) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China High Blood Pressure Drugs (Hypertension) Production Growth Rate Forecast 2019-2025 (K Units)
Figure China High Blood Pressure Drugs (Hypertension) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan High Blood Pressure Drugs (Hypertension) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan High Blood Pressure Drugs (Hypertension) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia High Blood Pressure Drugs (Hypertension) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia High Blood Pressure Drugs (Hypertension) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India High Blood Pressure Drugs (Hypertension) Production Growth Rate Forecast 2019-2025 (K Units)
Figure India High Blood Pressure Drugs (Hypertension) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of High Blood Pressure Drugs (Hypertension) by Type (2019-2025)
Table Global Consumption (K Units) of High Blood Pressure Drugs (Hypertension) by Application (2019-2025)
Table High Blood Pressure Drugs (Hypertension) Distributors List
Table High Blood Pressure Drugs (Hypertension) Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Eli Lilly、Pfizer、Bayer、Symplmed、Novartis、Merck、Sanofi、Boryung、Reata Pharmaceuticals、Lung Biotechnology、Yuhan、Takeda、Alvogen、

★調査レポート[世界の高血圧薬市場 2019年] (コード:DATA909X09003)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の高血圧薬市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆